Opportunity Information: Apply for CDC RFA DD10 1010
Apply for CDC RFA DD10 1010
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.073 Birth Defects and Developmental Disabilities Prevention and Surveillance.
- This funding opportunity was created on Apr 30, 2010 and posted on Apr 30, 2010.
- Applicants must submit their applications by Jun 1, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $900,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non US) entity A Bona Fide Agent is an agency/organization identified by the state or country government as eligible to submit an application under the state/country eligibility in lieu of a state/country application. If applying as a bona fide agent of a state or country government, a letter from the state agency or country Ministry of Health as documentation of the status is required.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC cooperative agreement funding opportunity (CDC RFA DD10-1010), titled "Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries," is designed to strengthen how low- and middle-income countries identify, track, and ultimately prevent serious birth defects, with particular attention to neural tube defects such as spina bifida and anencephaly. The core aim is twofold: first, to support the development, implementation, expansion, and evaluation of population-based birth defects surveillance systems, and second, to support planning efforts that lead to population-based programs intended to prevent birth defects. The work aligns with the Healthy People 2010 focus area of Maternal, Infant, and Child Health, emphasizing that birth defects prevention and monitoring are essential components of improving early-life health outcomes.
In practical terms, the opportunity is centered on building or improving national or regional systems that can consistently detect and record birth defects across a defined population, rather than relying on isolated facility reports or small research studies. Surveillance systems of this kind typically require clear case definitions, standardized reporting procedures, trained staff, reliable data collection tools, quality assurance processes, and strong linkages with hospitals, clinics, and vital records offices where births and outcomes are documented. The inclusion of "evaluation" and "expansion" signals that CDC anticipated proposals not only from places starting from scratch, but also from applicants who already had some surveillance capacity and needed resources to broaden geographic coverage, improve data quality, or assess whether their existing methods were producing accurate and usable estimates.
A second major piece of the program focuses on planning for prevention. While surveillance provides the evidence base (for example, establishing baseline prevalence of NTDs, identifying geographic or demographic patterns, and documenting trends over time), prevention planning is about translating data into action through population-wide strategies. For NTDs, prevention planning often involves folic acid interventions and related policy approaches, health education, clinical guidance, and consideration of fortification or supplementation strategies that can reach women of reproductive age. The announcement frames this as "planning" for programs, which suggests applicants were expected to lay the groundwork for prevention initiatives by assessing feasibility, identifying partners, mapping existing nutrition or maternal health infrastructure, and designing implementation approaches that fit local contexts.
The award mechanism is a cooperative agreement, meaning recipients would not simply receive funds and operate independently; instead, the CDC would be expected to have substantial involvement in the project, such as providing technical input, collaborating on surveillance methods, supporting evaluation approaches, and helping ensure that outputs meet public health standards. The funding activity category is Health, and it is linked to CFDA number 93.073 (Birth Defects and Developmental Disabilities Prevention and Surveillance).
Funding was relatively modest but structured to support a small portfolio of projects. CDC anticipated making 3 awards, with an estimated total funding amount of $900,000. Individual awards were expected to fall between $100,000 (floor) and $150,000 (ceiling). There was no cost sharing or matching requirement, which generally reduces barriers for applicants, especially those in low-resource settings.
Eligibility was broad and intentionally inclusive, encompassing many organization types that could realistically carry out surveillance and prevention planning. Eligible applicants included nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small/minority/women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal entities and tribal epidemiology centers, and state/local governments and their bona fide agents. Importantly, non-U.S. entities were eligible, consistent with the program focus on low- and middle-income countries. For applicants applying as a bona fide agent of a government, documentation was required in the form of a letter from the relevant state agency or country Ministry of Health confirming that status, reflecting CDCs emphasis on governmental alignment and authorization when a non-government organization applies on a governments behalf.
The opportunity timeline indicates it was posted on April 30, 2010, with an application deadline of June 1, 2010, and an archive date of July 1, 2010. For applicant support, the announcement directs technical or access-related questions to the CDC Procurement and Grants Office, with a listed phone number (770-488-2700) and email contact (pgotim@cdc.gov), which would have served as the entry point for obtaining the full announcement or resolving submission issues.
Overall, the grant opportunity reflects a public health strategy that treats surveillance and prevention as linked steps: build dependable population-based data systems for NTDs and other birth defects, use those systems to understand local burden and patterns, and then use that evidence to plan prevention programs that can reduce avoidable disability and death and improve maternal and child health outcomes at the population level.
FAQs: CDC RFA DD10-1010 - Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries
What is the name and identifier of this funding opportunity?
The opportunity is a CDC cooperative agreement titled "Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries," identified as CDC RFA DD10-1010.
What is the main purpose of this cooperative agreement?
The core purpose is to strengthen how low- and middle-income countries identify, track, and ultimately prevent serious birth defects. The work has two main aims: (1) support development, implementation, expansion, and evaluation of population-based birth defects surveillance systems, and (2) support planning efforts that lead to population-based programs intended to prevent birth defects.
Which birth defects are emphasized in this program?
The announcement highlights neural tube defects (NTDs) in particular, including spina bifida and anencephaly, while also covering other birth defects.
What does "population-based surveillance" mean in this context?
It refers to systems designed to consistently detect and record birth defects across a defined population (for example, a nation or region), rather than relying only on isolated facility reports or small research studies.
What kinds of activities are supported under the surveillance component?
Supported activities include developing, implementing, expanding, and evaluating birth defects surveillance systems. The description points to typical elements such as clear case definitions, standardized reporting procedures, trained staff, reliable data collection tools, quality assurance processes, and linkages with hospitals, clinics, and vital records offices where births and outcomes are documented.
Is this opportunity only for countries starting new surveillance systems?
No. The inclusion of "expansion" and "evaluation" indicates CDC anticipated proposals both from settings starting from scratch and from applicants with existing capacity who need support to broaden coverage, improve data quality, or assess whether methods produce accurate and usable estimates.
What is the prevention planning component meant to accomplish?
Prevention planning is intended to translate surveillance data into action by laying the groundwork for population-based strategies to prevent birth defects. The announcement frames this as planning for programs, including assessing feasibility, identifying partners, mapping existing nutrition or maternal health infrastructure, and designing approaches appropriate for local contexts.
How does surveillance data support prevention planning for NTDs?
Surveillance can establish baseline prevalence of NTDs, identify geographic or demographic patterns, and document trends over time. That evidence base can then inform prevention planning and guide population-wide strategies.
What prevention strategies are mentioned for neural tube defects?
The description notes that prevention planning for NTDs often involves folic acid interventions and related policy approaches, health education, clinical guidance, and consideration of fortification or supplementation strategies that can reach women of reproductive age.
What type of award mechanism is used?
This is a cooperative agreement, which means CDC is expected to have substantial involvement in the project rather than the recipient operating entirely independently.
What does CDC "substantial involvement" imply for recipients?
Based on the announcement summary, CDC involvement may include technical input, collaboration on surveillance methods, support for evaluation approaches, and helping ensure outputs meet public health standards.
What is the funding category and CFDA number associated with this opportunity?
The funding activity category is Health, and the opportunity is linked to CFDA 93.073 (Birth Defects and Developmental Disabilities Prevention and Surveillance).
How many awards did CDC anticipate making?
CDC anticipated making 3 awards.
What was the estimated total funding amount?
The estimated total funding amount was $900,000.
What is the expected funding range per award?
Individual awards were expected to range from $100,000 (floor) to $150,000 (ceiling).
Is cost sharing or matching required?
No. The announcement states there was no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small/minority/women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal entities and tribal epidemiology centers, and state/local governments and their bona fide agents.
Are non-U.S. organizations eligible?
Yes. Non-U.S. entities were eligible, consistent with the focus on low- and middle-income countries.
What is required if applying as a bona fide agent of a government?
Documentation is required in the form of a letter from the relevant state agency or country Ministry of Health confirming bona fide agent status.
When was the opportunity posted and what were the key dates?
The opportunity was posted on April 30, 2010. The application deadline was June 1, 2010. The archive date was July 1, 2010.
Who should applicants contact for technical or access-related questions?
The announcement directs questions to the CDC Procurement and Grants Office. The listed phone number is 770-488-2700 and the email contact is pgotim@cdc.gov.
How does this opportunity relate to broader public health goals?
The work aligns with Healthy People 2010, within the Maternal, Infant, and Child Health focus area, emphasizing that birth defects prevention and monitoring are key to improving early-life health outcomes.
What overall approach does this opportunity reflect?
It reflects a linked strategy: build dependable population-based surveillance systems for NTDs and other birth defects, use the data to understand local burden and patterns, and then use that evidence to plan prevention programs intended to reduce avoidable disability and death and improve maternal and child health outcomes.
Browse more opportunities from the same category: Health
Next opportunity: Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology (T32)
Previous opportunity: Renewable Energy Systems and Energy Efficiency Improvements
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD10 1010
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD10 1010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers Apply for CDC RFA DD10 1008 Funding Number: CDC RFA DD10 1008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pathogens (R01) Apply for RFA AI 10 010 Funding Number: RFA AI 10 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Innovative Strategies for Serving Children and Youth with Epilepsy (Project Access) Apply for HRSA 10 100 Funding Number: HRSA 10 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Areas (SAC AA) Apply for HRSA 10 223 Funding Number: HRSA 10 223 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| American Red Cross, San Juan Puerto Rico Apply for CDC RFA CK 10 006E Funding Number: CDC RFA CK 10 006E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Asthma and Indoor and Outdoor Air Quality Education Program Apply for CDC RFA EH10 1007 Funding Number: CDC RFA EH10 1007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| Teenage Pregnancy Prevention Integrating Services, Programs, and Strategies through Community wide Initiatives Apply for CDC RFA DP10 1009 Funding Number: CDC RFA DP10 1009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 10 185 Funding Number: PAR 10 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 10 186 Funding Number: PAR 10 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 10 184 Funding Number: PAR 10 184 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program Project on Alcohol Related Research (P01) Apply for PAR 10 187 Funding Number: PAR 10 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tribal Tobacco Control Programs to Reduce Commercial Tobacco Use Among American Indians and Alaska Natives Apply for CDC RFA DP10 1002 Funding Number: CDC RFA DP10 1002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $340,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 10 151 Funding Number: HRSA 10 151 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| First Time Motherhood/New Parents Initiative Apply for HRSA 10 035 Funding Number: HRSA 10 035 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Telehealth Network Grant Program Apply for HRSA 10 213 Funding Number: HRSA 10 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| MCH Research Network Programs Apply for HRSA 10 163 Funding Number: HRSA 10 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Funded Community Health Centers and Title X Programs Apply for CDC RFA DD10 1006 Funding Number: CDC RFA DD10 1006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| Occupational Safety and Health Research (R01) Apply for PAR 10 188 Funding Number: PAR 10 188 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Training Center Apply for HRSA 10 270 Funding Number: HRSA 10 270 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Multi Component Youth/Young Adult Alcohol Prevention Trials (R01) Apply for RFA AA 11 001 Funding Number: RFA AA 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD10 1010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.